ArticleInvestigational new drugs2016

A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041).

Joanne W Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.